The Bioprint Facility for Translational Science and Medicine in the MTP Sector
This project will provide engagement and commercialisation assistance for at least three SME's in progressing their BioInk or related production / delivery system.
The University of Wollongong are creating a Bio-Printing facility to expedite the development of commercial opportunities in 3D bioprinting. This project will provide the technical expertise and facilities to enable the development of commercial opportunities identified by the clinical partners and SMEs for the production of relevant biomaterials, formulations of bioinks or customised bioprinting systems.
Outcomes (FY2020):
- A new facility (TRICEP - Translational Research Initiative of Cellular Engineering and Printing) has been established at Wollongong.
- Ten new products have been developed within the facility, with two new startup companies formed.
- TRICEP have supported over 100 inbound and outbound missions through speakers and facility tours.
Visit the University of Wollongong for more details.
Twitter: UOW
LinkedIn: University of Wollongong
| Consortium lead | University of Wollongong |
| Consortium members | Venus Shell Systems, SMR Automotive Australia Pty Limited, University of Sydney, St Vincent’s Hospital (Melbourne) & Lincoln Consulting Group |
| MTPConnect grant | $400,000 |
| Industry contribution | $400,000 |
| Project duration | March 2018 - August 2019 (Completed) |
| Contact | Professor Gordon Wallace, University of Wollongong - gwallace@uow.edu.au |